MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$30,092
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-03-31
2024-12-31
2024-09-30
Interest expense
11,429
11,131
10,250
Amortization of discount on convertible notes
4,363
4,314
6,044
Total other income (expense)
-15,792
-15,445
-16,294
Professional fees
9,340
16,020
12,680
General and administrative
4,960
8,007
3,030
Total operating expenses
14,300
24,027
15,710
Net loss
-30,092
-39,472
-32,004
Basic EPS
0
0
0
Diluted EPS
0
0
0
Basic Average Shares
70,772,196
70,765,603
70,472,196
Diluted Average Shares
70,772,196
70,765,603
70,472,196
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$30,092
Total other income
(expense)
-$15,792
Total operating
expenses
$14,300
Interest expense
$11,429
Amortization of discount on
convertible notes
$4,363
Professional fees
$9,340
General and
administrative
$4,960
Buy us a coffee
NEXIEN BIOPHARMA, INC. (NXEN)
NEXIEN BIOPHARMA, INC. (NXEN)